The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Translational control in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Sonenberg, N., & Hinnebusch, A. G. (2009) · Cell · doi:10.1016/j.cell.2009.01.042 · Cited by 3,304
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803
Liu, L., Cao, Y., Chen, C., Zhang, X., McNabola, A., Wilkie, D., Wilhelm, S., Lynch, M., & Carter, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1377 · Cited by 1,536
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326
Coping with stress: eIF2 kinases and translational control
Wek, R. C., Jiang, H.-Y., & Anthony, T. G. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340007 · Cited by 1,289
Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Haar, E. V., Lee, S.-I., Bandhakavi, S., Griffin, T. J., & Kim, D.-H. (2007) · Nature Cell Biology · doi:10.1038/ncb1547 · Cited by 1,190
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., & Shokat, K. M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000038 · Cited by 1,082
Current development of mTOR inhibitors as anticancer agents
Faivre, S., Kroemer, G., & Raymond, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2062 · Cited by 1,000
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 956
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2
Waskiewicz, A. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1909 · Cited by 947
Does the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928
Hypoxia signalling through mTOR and the unfolded protein response in cancer
Wouters, B. G., & Koritzinsky, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2501 · Cited by 894
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731
ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
Bi, M., Naczki, C., Koritzinsky, M., Fels, D., Blais, J., Hu, N., Harding, H., Novoa, I., Varia, M., Raleigh, J., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600777 · Cited by 729
eIF-4E expression and its role in malignancies and metastases
De Benedetti, A., & Graff, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207545 · Cited by 728
Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15587 · Cited by 674
Translational control in biology and medicine
Mathews, M. B., Sonenberg, N., & Hershey, J. W. B. (2007) · Cited by 661
Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E
Pyronnet, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.270 · Cited by 639
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.
Yang, Y. L., Reis, L. F., Pavlovic, J., Aguzzi, A., Schäfer, R., Kumar, A., Williams, B. R., Aguet, M., & Weissmann, C. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00300.x · Cited by 632
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 586
Moerke, N. J., Aktas, H., Chen, H., Cantel, S., Reibarkh, M. Y., Fahmy, A., Gross, J. D., Degterev, A., Yuan, J., Chorev, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.046 · Cited by 572
Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase
Koromilas, A. E., Roy, S., Barber, G. N., Katze, M. G., & Sonenberg, N. (1992) · Science · doi:10.1126/science.1382315 · Cited by 531
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 531
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494
Dissecting eIF4E action in tumorigenesis
Wendel, H.-G., Silva, R. L. A., Malina, A., Mills, J. R., Zhu, H., Ueda, T., Watanabe-Fukunaga, R., Fukunaga, R., Teruya-Feldstein, J., Pelletier, J., et al. (2007) · Genes & Development · doi:10.1101/gad.1604407 · Cited by 487
Waskiewicz, A. J., Johnson, J. C., Penn, B., Mahalingam, M., Kimball, S. R., & Cooper, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1871 · Cited by 469
Hypusine-containing protein eIF5A promotes translation elongation
Saini, P., Eyler, D. E., Green, R., & Dever, T. E. (2009) · Nature · doi:10.1038/nature08034 · Cited by 431
An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer
Zender, L., Xue, W., Zuber, J., Semighini, C. P., Krasnitz, A., Ma, B., Zender, P., Kubicka, S., Luk, J. M., Schirmacher, P., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.061 · Cited by 428
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Barna, M., Pusic, A., Zollo, O., Costa, M., Kondrashov, N., Rego, E., Rao, P. H., & Ruggero, D. (2008) · Nature · doi:10.1038/nature07449 · Cited by 424
Koromilas, A. E., Lazaris-Karatzas, A., & Sonenberg, N. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05508.x · Cited by 419
Koritzinsky, M., Magagnin, M. G., van den Beucken, T., Seigneuric, R., Savelkouls, K., Dostie, J., Pyronnet, S., Kaufman, R. J., Weppler, S. A., Voncken, J. W., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600998 · Cited by 363
What is the restriction point?
Zetterberg, A., Larsson, O., & Wiman, K. G. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80067-0 · Cited by 351
Tuberous Sclerosis: from Tubers to mTOR
Kwiatkowski, D. J. (2003) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2003.00012.x · Cited by 339
Targeting the Eukaryotic Translation Initiation Factor 4E for Cancer Therapy
Graff, J. R., Konicek, B. W., Carter, J. H., & Marcusson, E. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5635 · Cited by 332
Bordeleau, M.-E., Robert, F., Gerard, B., Lindqvist, L., Chen, S. M. H., Wendel, H.-G., Brem, B., Greger, H., Lowe, S. W., Porco, J. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34753 · Cited by 332
Zhou, X., Tan, M., Stone Hawthorne, V., Klos, K. S., Lan, K.-H., Yang, Y., Yang, W., Smith, T. L., Shi, D., & Yu, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0112 · Cited by 312
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation
Lankat‐Buttgereit, B., & Göke, R. (2009) · Biology of the Cell · doi:10.1042/bc20080191 · Cited by 311
A Hypoxia-Controlled Cap-Dependent to Cap-Independent Translation Switch in Breast Cancer
Braunstein, S., Karpisheva, K., Pola, C., Goldberg, J., Hochman, T., Yee, H., Cangiarella, J., Arju, R., Formenti, S. C., & Schneider, R. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.10.019 · Cited by 308
Self-citationAntitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
Cencic, R., Carrier, M., Galicia-Vázquez, G., Bordeleau, M.-E., Sukarieh, R., Bourdeau, A., Brem, B., Teodoro, J. G., Greger, H., Tremblay, M. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005223 · Cited by 302
Donzé, O., Jagus, R., Koromilas, A. E., Hershey, J. W., & Sonenberg, N. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00052.x · Cited by 288
Rahmani, M., Davis, E. M., Bauer, C., Dent, P., & Grant, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506551200 · Cited by 288
Holcik, M., Yeh, C., Korneluk, R. G., & Chow, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203765 · Cited by 259
Rosenwald, I. B., Rhoads, D. B., Callanan, L. D., Isselbacher, K. J., & Schmidt, E. V. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6175 · Cited by 255
Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer
Silvera, D., Arju, R., Darvishian, F., Levine, P. H., Zolfaghari, L., Goldberg, J., Hochman, T., Formenti, S. C., & Schneider, R. J. (2009) · Nature Cell Biology · doi:10.1038/ncb1900 · Cited by 244
Self-citationEukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation
Gandin, V., Miluzio, A., Barbieri, A. M., Beugnet, A., Kiyokawa, H., Marchisio, P. C., & Biffo, S. (2008) · Nature · doi:10.1038/nature07267 · Cited by 236
Evans, J. R., Mitchell, S. A., Spriggs, K. A., Ostrowski, J., Bomsztyk, K., Ostarek, D., & Willis, A. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206645 · Cited by 233
Abraham, N., Stojdl, D. F., Duncan, P. I., Méthot, N., Ishii, T., Dubé, M., Vanderhyden, B. C., Atkins, H. L., Gray, D. A., McBurney, M. W., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5953 · Cited by 231
Epigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation
Mamane, Y., Petroulakis, E., Martineau, Y., Sato, T.-A., Larsson, O., Rajasekhar, V. K., & Sonenberg, N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000242 · Cited by 224
Connolly, E., Braunstein, S., Formenti, S., & Schneider, R. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3955-3965.2006 · Cited by 219
Self-citationChoo, A. Y., & Blenis, J. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7659 · Cited by 210
Yu, K., Shi, C., Toral-Barza, L., Lucas, J., Shor, B., Kim, J. E., Zhang, W.-G., Mahoney, R., Gaydos, C., Tardio, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2340 · Cited by 206
Zhang, L., Pan, X., & Hershey, J. W. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606284200 · Cited by 204
Graff, J. R., Konicek, B. W., Lynch, R. L., Dumstorf, C. A., Dowless, M. S., McNulty, A. M., Parsons, S. H., Brail, L. H., Colligan, B. M., Koop, J. W., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3472 · Cited by 202
Tamburini, J., Green, A. S., Bardet, V., Chapuis, N., Park, S., Willems, L., Uzunov, M., Ifrah, N., Dreyfus, F., Lacombe, C., et al. (2009) · Blood · doi:10.1182/blood-2008-10-184515 · Cited by 190
Lazaris-Karatzas, A., & Sonenberg, N. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.1234 · Cited by 168
Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer
Dong, Z., & Zhang, J.-T. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.03.005 · Cited by 163
Larsson, O., Li, S., Issaenko, O. A., Avdulov, S., Peterson, M., Smith, K., Bitterman, P. B., & Polunovsky, V. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0752 · Cited by 163
Malignant transformation by overproduction of translation initiation factor eIF4G.
Shimogori, T., Ishii, I., Kashiwagi, K., Mashiba, H., EKIMOTO, H., & Igarashi, K. (1997) · PubMed · Cited by 159
Schewe, D. M., & Aguirre‐Ghiso, J. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3858 · Cited by 156
Nupponen, N. N., Porkka, K., Kakkola, L., Tanner, M., Persson, K., Borg, Å., Isola, J. J., & Visakorpi, T. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65433-8 · Cited by 151
Marchetti, A., Buttitta, F., Miyazaki, S., Gallahan, D., Smith, G. H., & Callahan, R. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1932-1938.1995 · Cited by 146
Ras mediates translation initiation factor 4E-induced malignant transformation.Preprint
Lazaris-Karatzas, A., Smith, M. R., Frederickson, R., Jaramillo, M., Yl, L., Kung, H. F., & Sonenberg, N. (1992) · Genes & Development · doi:10.1101/gad.6.9.1631 · Cited by 145
Regulation of Protein Synthesis by Ionizing Radiation
Braunstein, S. E., Badura, M. L., Xi, Q., Formenti, S. C., & Schneider, R. J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00711-09 · Cited by 142
Self-citationOncogenic Role of eIF-5A2 in the Development of Ovarian Cancer
Guan, X., Fung, J. M.-W., Ma, N., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3747 · Cited by 141
Chappell, S. A., Quesne, J. P. C. L., Paulin, F., deSchoolmeester, M. L., Stoneley, M., Soutar, R. L., Ralston, S. H., Helfrich, M., & Willis, A. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203791 · Cited by 138
Enhanced expression of translation factor mRNAs in hepatocellular carcinoma.
Shuda, M., Kondoh, N., Tanaka, K., et al. (2000) · PubMed · Cited by 129
Brass, N. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.1.33 · Cited by 128
Eukaryotic initiation factor 6 mediates a continuum between 60S ribosome biogenesis and translation
Miluzio, A., Beugnet, A., Volta, V., & Biffo, S. (2009) · EMBO Reports · doi:10.1038/embor.2009.70 · Cited by 127
PRAS40 Deregulates Apoptosis in Malignant Melanoma
Madhunapantula, S. V., Sharma, A. K., & Robertson, G. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4234 · Cited by 123
Coleman, L., Peter, M. B., Teall, T. J., Brannan, R. A., Hanby, A. M., Honarpisheh, H., Shaaban, A. M., Smith, L., Speirs, V., Verghese, E. T., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605044 · Cited by 122
Shi, J., Kahle, A. C., Hershey, J. W. B., Honchak, B. M., Warneke, J. A., Leong, S. P. L., & Nelson, M. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209495 · Cited by 122
Amplification of EIF3S3 Gene Is Associated with Advanced Stage in Prostate Cancer
Saramäki, O. R., Willi, N., Ola Bratt, A., Gasser, T. C., Koivisto, P., Nupponen, N. N., Bubendorf, L., & Visakorpi, T. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63060-x · Cited by 118
Eberle, J., Krasagakis, K., & Orfanos, C. E. (1997) · International Journal of Cancer · Cited by 118
Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth
Dong, Z., Liu, L. H., Han, B., Pincheira, R., & Zhang, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207465 · Cited by 117
PI3K inhibitors for cancer treatment: where do we stand?
Maira, S.-M., Stauffer, F., Schnell, C., & García-Echeverría, C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370265 · Cited by 113
Tumorigenic activity and therapeutic inhibition of Rheb GTPasePreprint
Mavrakis, K. J., Zhu, H., Silva, R. L. A., Mills, J. R., Teruya‐Feldstein, J., Lowe, S. W., Tam, W., Pelletier, J., & Wendel, H. (2008) · Genes & Development · doi:10.1101/gad.1690808 · Cited by 113
Fan, S., Ramalingam, S. S., Kauh, J. S. W., Xu, Z., Khuri, F. R., & Sun, S. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.15.8960 · Cited by 111
Johnson, L. F., Levis, R. W., Abelson, H. T., Green, H., & Penman, S. (1976) · The Journal of Cell Biology · doi:10.1083/jcb.71.3.933 · Cited by 111
Effect of cell proliferation on levels and diversity of poly(A)-containing mRNA
Getz, M. J., Elder, P. K., Benz, E. W., Stephens, R. E., & Moses, H. L. (1976) · Cell · doi:10.1016/0092-8674(76)90025-8 · Cited by 109
Umar, A., Kang, H., Timmermans, A. M., Look, M. P., Gelder, M. E. M., den Bakker, M. A., Jaitly, N., Martens, J. W. M., Luider, T. M., Foekens, J. A., et al. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800493-mcp200 · Cited by 108
Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR
Kim, S. H., Forman, A. P., Mathews, M. B., & Gunnery, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203632 · Cited by 106
EIF3 p170, a Mediator of Mimosine Effect on Protein Synthesis and Cell Cycle Progression
Dong, Z., & Zhang, J. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0784 · Cited by 106
Flavin, R., Smyth, P. C., Finn, S. P., Laios, A., O’Toole, S. A., Barrett, C., Ring, M., Denning, K. M., Li, J., Aherne, S. T., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.33 · Cited by 105
Comtesse, N., Keller, A., Diesinger, I., Bauer, C., Kayser, K., Huwer, H., Lenhof, H., & Meese, E. U. (2007) · International Journal of Cancer · doi:10.1002/ijc.22585 · Cited by 104
Balabanov, S., Gontarewicz, A., Ziegler, P., Hartmann, U., Kammer, W., Copland, M., Brassat, U., Priemer, M., Hauber, I., Wilhelm, T., et al. (2006) · Blood · doi:10.1182/blood-2005-03-037648 · Cited by 96
Reduced expression of INT-6/eIF3-p48 in human tumors.
Marchetti, A., Buttitta, F., Pellegrini, S., Bertacca, G., & Callahan, R. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.1.175 · Cited by 83
Bauer, C., Brass, N., Diesinger, I., Kayser, K., Grässer, F. A., & Meese, E. U. (2001) · International Journal of Cancer · doi:10.1002/ijc.10180 · Cited by 80
Avruch, J., Long, X., Lin, Y., Ortiz-Vega, S., Rapley, J., Papageorgiou, A., Oshiro, N., & Kikkawa, U. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370223 · Cited by 78
Structural Basis for Inhibition of Translation by the Tumor Suppressor Pdcd4
LaRonde-LeBlanc, N. A., Santhanam, A. N., Baker, A. R., Wlodawer, A., & Colburn, N. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00867-06 · Cited by 77
Shi, Y., Frost, P., Hoang, B. Q., Benavides, A., Sharma, S., Gera, J., & Lichtenstein, A. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1066 · Cited by 75
Canonical Initiation Factor Requirements of the Myc Family of Internal Ribosome Entry Segments
Spriggs, K. A., Cobbold, L. C., Jopling, C. L., Cooper, R. E., Wilson, L. A., Stoneley, M., Coldwell, M. J., Poncet, D., Shen, Y.-C., Morley, S., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01283-08 · Cited by 74
Evidence for the transforming activity of a truncated Int6 gene, in vitro
Rasmussen, S. B., Kordon, E. C., Callahan, R., & Smith, G. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204624 · Cited by 72
p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus
Chen, G., & Burger, M. M. (1999) · International Journal of Cancer · Cited by 70
Carayol, N., Katsoulidis, E., Sassano, A., Altman, J. K., Druker, B. J., & Platanias, L. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707934200 · Cited by 70
Bauer, C., Diesinger, I., Brass, N., Steinhart, H., Iro, H., & Meese, E. U. (2001) · Cancer · Cited by 69
Expression of a highly conserved protein, p27BBP, during the progression of human colorectal cancer.
Sanvito, F., Vivoli, F., Gambini, S., Santambrogio, G., Catena, M., Viale, E., Veglia, F., Donadini, A., Biffo, S., & Marchisio, P. C. (2000) · PubMed · Cited by 68
Lin, C., Malina, A., & Pelletier, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0813 · Cited by 67
Jopling, C. L., & Willis, A. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204404 · Cited by 64
Cappuzzo, F., Varella‐Garcia, M., Rossi, E., Gajapathy, S., Valente, M., Drabkin, H. A., & Gemmill, R. M. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31819a5767 · Cited by 61
S6K1 Plays a Key Role in Glial Transformation
Nakamura, J. L., Garcia, E., & Pieper, R. O. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6188 · Cited by 61
Salehi, Z., & Mashayekhi, F. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.11.007 · Cited by 57
Targeting the eIF4F translation initiation complex for cancer therapy
Konicek, B. W., Dumstorf, C. A., & Graff, J. R. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6464 · Cited by 57
Targeting Translation for Treatment of Cancer - A Novel Role for IRES?
Holčı́k, M. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043333005 · Cited by 56
Scoles, D. R., Yong, W. H., Qin, Y., Wawrowsky, K., & Pulst, S. M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl021 · Cited by 56
Inflammatory breast cancer cells are constitutively adapted to hypoxia
Silvera, D., & Schneider, R. J. (2009) · Cell Cycle · doi:10.4161/cc.8.19.9637 · Cited by 55
Self-citationWang, S., Lloyd, R. V., Hutzler, M., Rosenwald, I. B., Safran, M., Patwardhan, N. A., & Khan, A. A. (2001) · Thyroid · doi:10.1089/10507250152740939 · Cited by 52
Shimada, A., Shiota, G., Miyata, H., Kamahora, T., Kawasaki, H., Shiraki, K., Hino, S., & Terada, T. (1998) · PubMed · Cited by 49
Expression of the Double-Stranded RNA-Dependent Protein Kinase (p68) in Human Breast Tissues
Haines, G. K., Cajulis, R. S., Hayden, R., Duda, R. B., Talamonti, M., & Radosevich, J. A. (1996) · Tumor Biology · doi:10.1159/000217961 · Cited by 47
Activation of mTOR in a subgroup of ovarian carcinomas: Correlation with p-eIF-4E and prognosis
Noske (1994) · Oncology Reports · doi:10.3892/or_00000160 · Cited by 46
Translational control: A target for cancer therapy
Thumma, S. C., & Kratzke, R. A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.022 · Cited by 45
Tejada, S., Lobo, M. V. T., García-Villanueva, M., Sacristán, S., Pérez-Morgado, M. I., Salinas, M., & Martín, M. E. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.952929 · Cited by 43
Johnson, M. D., O’Connell, M., Vito, F., & Bakos, R. S. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9746-7 · Cited by 41
Impact of XIAP protein levels on the survival of myeloma cells
Desplanques, G., Giuliani, N., Delsignore, R., Rizzoli, V., Bataille, R., & Barillé‐Nion, S. (2008) · Haematologica · doi:10.3324/haematol.13483 · Cited by 39
Kim, S. H., Miller, F. R., Tait, L. R., Zheng, J., & NOVAK, R. F. (2009) · International Journal of Cancer · doi:10.1002/ijc.24278 · Cited by 38
The nucleoli of cultured human lymphocytes
Gani, R. (1976) · Experimental Cell Research · doi:10.1016/0014-4827(76)90614-5 · Cited by 37
Haines, G. K., Panos, R. J., Bak, P. M., Brown, T., Zielinski, M., Leyland, J., & Radosevich, J. A. (1998) · Tumor Biology · doi:10.1159/000029974 · Cited by 33
Terada, T., Maeta, H., Endo, K., & Ohta, T. (2000) · Human Pathology · doi:10.1053/hupa.2000.8443 · Cited by 30
Mack, D. L., Boulanger, C. A., Callahan, R., & Smith, G. H. (2007) · Breast Cancer Research · doi:10.1186/bcr1742 · Cited by 30
Haines, G. K., Becker, S., Ghadge, G. D., Kies, M. S., Pelzer, H. J., & Radosevich, J. A. (1993) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1993.01880220098012 · Cited by 28
Research works printed but not linked: 23
- Pianese, G. Beitrag zur histologie und Aetiologie der carcinoma histologische und experimentelle. Beitr. Pathol. Anat. Allgem. Pathol. 142, 1–193 (1896).
- Mayeur, G. L. & Hershey, J. W. Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett. 514, 49–54 (2002). · doi:10.1016/s0014-5793(02)02307-4
- Zanelli, C. F. & Valentini, S. R. Is there a role for eIF5A in translation? Amino Acids 33, 351–358 (2007). · doi:10.1007/s00726-007-0533-0
- Jenkins, Z. A., Haag, P. G. & Johansson, H. E. Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics 71, 101–109 (2001). · doi:10.1006/geno.2000.6418
- Benne, R., Brown-Luedi, M. L. & Hershey, J. W. Purification and characterization of protein synthesis initiation factors eIF-1, eIF-4C, eIF-4D, and eIF-5 from rabbit reticulocytes. J. Biol. Chem. 253, 3070–3077 (1978). · doi:10.1016/s0021-9258(17)40804-0
- Kemper, W. M., Berry, K. W. & Merrick, W. C. Purification and properties of rabbit reticulocyte protein synthesis initiation factors M2Bα and M2Bβ. J. Biol. Chem. 251, 5551–5557 (1976). · doi:10.1016/s0021-9258(17)33095-8
- Hanauske-Abel, H. M. et al. Detection of a sub-set of polysomal mRNAs associated with modulation of hypusine formation at the G1-S boundary. Proposal of a role for eIF-5A in onset of DNA replication. FEBS Lett. 366, 92–98 (1995). · doi:10.1016/0014-5793(95)00493-s
- Cracchiolo, B. M. et al. Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulva. Gynecol. Oncol. 94, 217–222 (2004). · doi:10.1016/j.ygyno.2004.03.018
- Rosso, P. et al. Overexpression of p27BBP in head and neck carcinomas and their lymph node metastases. Head Neck 26, 408–417 (2004). · doi:10.1002/hed.10401
- Rosenwald, I. B., Hutzler, M. J., Wang, S., Savas, L. & Fraire, A. E. Expression of eukaryotic translation initiation factors 4E and 2α is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung. Cancer 92, 2164–2171 (2001). · doi:10.1002/1097-0142(20011015)92:8<2164::aid-cncr1559>3.0.co;2-a
- Haines, G. K. et al. Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 63, 289–295 (1993). · doi:10.1007/bf02899275
- Rosenwald, I. B., Wang, S., Savas, L., Woda, B. & Pullman, J. Expression of translation initiation factor eIF-2α is increased in benign and malignant melanocytic and colonic epithelial neoplasms. Cancer 98, 1080–1088 (2003). · doi:10.1002/cncr.11619
- Wang, S. et al. Expression of the eukaryotic translation initiation factors 4E and 2α in non-Hodgkin's lymphomas. Am. J. Pathol. 155, 247–255 (1999). · doi:10.1016/s0002-9440(10)65118-8
- Rosenwald, I. B. et al. Expression of the translation initiation factors eIF-4E and eIF-2* is frequently increased in neoplastic cells of Hodgkin lymphoma. Hum. Pathol. 39, 910–916 (2008). · doi:10.1016/j.humpath.2007.10.021
- Bachmann, F., Banziger, R. & Burger, M. M. Cloning of a novel protein overexpressed in human mammary carcinoma. Cancer Res. 57, 988–994 (1997).
- Dellas, A. et al. Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer 83, 1376–1383 (1998). · doi:10.1002/(sici)1097-0142(19981001)83:7<1376::aid-cncr15>3.0.co;2-1
- Pincheira, R., Chen, Q. & Zhang, J. T. Identification of a 170-kDa protein over-expressed in lung cancers. Br. J. Cancer 84, 1520–1527 (2001). · doi:10.1054/bjoc.2001.1828
- Chen, G. & Burger, M. M. p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation. Int. J. Cancer 112, 393–398 (2004). · doi:10.1002/ijc.20443
- Rothe, M., Ko, Y., Albers, P. & Wernert, N. Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas. Am. J. Pathol. 157, 1597–1604 (2000). · doi:10.1016/s0002-9440(10)64797-9
- Guan, X. Y. et al. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res. 61, 3806–3809 (2001).
- Xie, D. et al. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum. Pathol. 39, 80–86 (2008). · doi:10.1016/j.humpath.2007.05.011
- Luo, J. H. et al. Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder. Cancer Sci. 100, 896–902 (2009). · doi:10.1111/j.1349-7006.2009.01126.x
- Chen, W. et al. Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy. Cancer Epidemiol. Biomarkers Prev. 18, 400–408 (2009). · doi:10.1158/1055-9965.epi-08-0754
Cited by
A census of human RNA-binding proteins
Gerstberger, S., Hafner, M., & Tuschl, T. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3813 · Cited by 2,032
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3557 · Cited by 1,673
Metabolic control of autophagy
Galluzzi, L., Pietrocola, F., Levine, B., & Kroemer, G. (2014) · Cell · doi:10.1016/j.cell.2014.11.006 · Cited by 855
Targeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
Metadata
- Authors
- Silvera, D., Formenti, S. C., & Schneider, R. J.
- Venue
- Nature Reviews Cancer
- Published
- 2010-04
- Volume
- 10
- Issue
- 4
- Pages
- 254-266
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2089716875
- Cited by
- 821
- References
- 125
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.